Haematological influences of potassium adaptation in normotensive and renally-hypertensive Wistar rats

References

• Sato Y, Katsuyuki A, Ogata E, Fujita T. High potassium diet attenuates salt-induced acceleration of hypertension in SHR. Am J Physiol 1991; 260: R21 – R26.
   Google Scholar
• Tolvanen JP, Maykyen H, Wu X et al. Effect of calcium and potassium supplements on arterial tone in spontaneously hypertensive rats. Br J Pharmacol 1998; 124: 119–28.
   Google Scholar
• Suzuki H, Kondo K, Satura T. Inhibitory effect of potassium on blood pressure in DOCA salt hypertensive rats. Acta Endocrinol 1981a; 97: 525–32.
   Google Scholar
• Suzuki H, Kondo K, Satura T. Effect of potassium chloride on blood pressure in two-kidney, one-clip Goldblatt hypertensive rats. Hypertension 1981b; 3: 566–73.
   Google Scholar
• Raij L, Luscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension 1988; 12: 562–67.
   Google Scholar
• Sacks FM, Brown LE, Appel L, Borhani NO, Evans D, Whelton P. Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension 1995; 26: 950–6.
   Google Scholar
• Sugimoto T, Tobian L, Ganguli, MC. High potassium diet protects against dysfunction of endothelial cells in stroke-prone spontaneously hypertensive rats. Hypertension 1988; 11: 579–85.
   Google Scholar
• Dolson GM, Wesson DE, Androgue HJ. Vascular relaxation probably mediates the antihypertensive effect of high potassium: a role for enhanced vascular Na,K-ATPase activity. J Hypertens 1995; 13: 1433–9.
   Google Scholar
• Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350–6.
   Google Scholar
• Riddell DR, Owen JS. Nitric oxide and platelet aggregation. Vitam Horm 1999 57: 25–48.
   Google Scholar
• Butterworth RJ, Cluckie A, Jackson SH, Buxton Thomas M, Bath PM. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998; 8: 158–65.
   Google Scholar
• de Silva HA, Carver JG, Aronson JK. Pharmacological evidence of calcium-activated and voltage-gated potassium channels in human platelets. Clin Sci 1997; 93: 249–55.
   Google Scholar
• Mcgrath MA, Penny R. Paraproteinemia: blood hyperviscosity and clinical manifestations. J Clin Invest 1976; 58: 1155.
   Google Scholar
• Grollman A. A simplified procedure for inducing chronic renal hypertension in the mammal. Proc Soc Exp Biol Med 1944; 57: 102–4.
   Google Scholar
• Eferakeya AE, Osunkwo UE. Failure of verapamil and diltiazem to attenuate the pressor response to hypothalamic stimulation: a possible mechanism. J Pharm Pharmacol 1992; 44: 433–9.
   Google Scholar
• Dacie JV, Lewis SM. Practical haematology, 7th Edn. Edinburgh: Churchill Livingstone, 1991: 13.
   Google Scholar
• Reid HL, Ugwu AC. A simple technique of rapid determination of plasma viscosity. Nig J Physiol Sci 1987; 3: 43–8.
   Google Scholar
• Famodu AA, Halim NKD, Odoemene DI, Eneh EE. Haemorheological changes in sickle cell disease: measurement and significance. Br J Biomed Sci 1998; 55: 265–7.
   Google Scholar
• Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 19: 924–6.
   Google Scholar
• George JN, El-Harake M. Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams’ hematology New York: McGraw-Hill, 1995: 1290–315.
   Google Scholar
• Famodu AA, Aigbe A. Haemorheological and fibrinolytic activity in hypertensive Nigerians. Clin Haemorheol Microcirc 1999; 21: 415–20.
   Google Scholar
• Reid LH, Ojogwu LI. Hyperfibrinogenemia and hyperviscous plasma in hypertensive Africans. Angiology 1992; 43: 826–32.
   Google Scholar
• Isles C, Lowe GDO, Rankin BM, Forbes CD, Lucie NAF, Kenned, AC. Abnormal haemostasis and blood viscosity in malignant hypertension. Thromb Haemostas 1984; 52: 253–5.
   Google Scholar
• Makris TK, Tsoukala C, Krespi P et al. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997; 88: 99–107.
   Google Scholar
• Brüne B, Hanstein K. Rapid reversibility of nitric oxide induced platelet inhibition. Thromb Res 1998; 90: 83–91.
   Google Scholar
• Yoshimoto H, Suehiro A, Kakishita E. Exogenous nitric oxide inhibits platelets activation in whole blood. J Cardiovasc Pharmacol 1999; 33: 109–15.
   Google Scholar
• Wang GR, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 1998; 95: 4888–93.
   Google Scholar
• Gries A, Bode C, Peter K et al. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation 1998; 97: 1481–7.
   Google Scholar
• Whiss PA, Andersson RGG, Srinivas U. Modulation of P-selectin expression on isolated human platelets by an NO donor assessed by a novel ELISA application. J Immunol Methods 1997; 200: 135–43.
   Google Scholar
• Pigazzi A, Heydrick S, Folli F, Benoit S, Michelson A, Loscalzo J. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J Biol Chem 1999; 274: 14368–75.
   Google Scholar
• de Silva HA, Aronson JK, Grahame-Smith DG, Jobst KA, Smith AD. Abnormal function of potassium channels in platelets of patients with Alzheimer’s disease. Lancet 1999; 353: 325–6.
   Google Scholar